12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Aubagio teriflunomide regulatory update

Sanofi's Genzyme Corp. unit said Health Canada approved Aubagio teriflunomideis as monotherapy to treat...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >